Sunday, June 14, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 990 of 1,261
  1. US 7786316

    Metalloprotein inhibitors

    The Regents of the University of California · Granted Aug 31, 2010 · Expires Aug 26, 2030

    granted
  2. US 7786120

    Pyridones useful as inhibitors of kinases

    Vertex Pharmaceuticals Incorporated · Granted Aug 31, 2010 · Expires Aug 26, 2030

    granted
  3. US 7786096

    Inhibition of antigen presentation with poorly catabolized polymers

    HALOZYME, INC. · Granted Aug 31, 2010 · Expires Aug 26, 2030

    granted
  4. US 7786308

    Muscarinic modulators

    Vertex Pharmaceuticals Incorporated · Granted Aug 31, 2010 · Expires Aug 26, 2030

    granted
  5. US 7786083

    Metastin derivatives and use thereof

    Takeda Pharmaceutical Company Limited · Granted Aug 31, 2010 · Expires Aug 26, 2030

    granted
  6. US 7788045

    Systems and method for homeostatic blood states

    MEDITASKS, LLC · Granted Aug 31, 2010 · Expires Aug 26, 2030

    granted
  7. US 7786165

    Aminophenylpropanoic acid derivative

    Takeda Pharmaceutical Company Limited · Granted Aug 31, 2010 · Expires Aug 26, 2030

    granted
  8. US 7786137

    Bicyclic derivatives as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Aug 31, 2010 · Expires Aug 26, 2030

    granted
  9. US 7784616

    Dispenser for progestin used for acute maintenance treatment of DUB

    TEVA WOMEN'S HEALTH, INC. · Granted Aug 31, 2010 · Expires Aug 26, 2030

    granted
  10. US 7785806

    Method for determining the immunogenicity of an antigen

    VaxDesign Corp. · Granted Aug 31, 2010 · Expires Aug 26, 2030

    granted
  11. US 7785597

    VMP-like sequences of pathogenic Borrelia

    The Board of Regents of the University of Texas System · Granted Aug 31, 2010 · Expires Aug 26, 2030

    granted
  12. US 7785886

    Methods and reagents for modulating cholesterol levels

    Xenon Pharmaceuticals Inc. · Granted Aug 31, 2010 · Expires Aug 26, 2030

    granted
  13. US 7786290

    Double-stranded ribonucleic acid with increased effectiveness in an organism

    Alnylam Pharmaceuticals, Inc. · Granted Aug 31, 2010 · Expires Aug 26, 2030

    granted
  14. US 7785565

    Metal chelators and methods of their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 31, 2010 · Expires Aug 26, 2030

    granted
  15. US 7786080

    Mutein of a bone morphogenetic protein and use thereof

    Julius-Maximilians-Universitat Wurzburg · Granted Aug 31, 2010 · Expires Aug 26, 2030

    granted
  16. US 7786091

    Compositions and methods for ameliorating myosin VIIa defects

    The Regents of the University of California · Granted Aug 31, 2010 · Expires Aug 26, 2030

    granted
  17. US 7786100

    Composition and method of treating hearing loss

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 31, 2010 · Expires Aug 26, 2030

    granted
  18. US 7786133

    Chemically modified small molecules

    Nektar Therapeutics · Granted Aug 31, 2010 · Expires Aug 26, 2030

    granted
  19. US 7786136

    Indazole-carboxamide compounds

    Theravance, Inc. · Granted Aug 31, 2010 · Expires Aug 26, 2030

    granted
  20. US 7786141

    Dihydrospiroindene modulators of muscarinic receptors

    Vertex Pharmaceuticals Incorporated · Granted Aug 31, 2010 · Expires Aug 26, 2030

    granted
  21. US 7786130

    Pyridones useful as inhibitors of kinases

    Vertex Pharmaceuticals Incorporated · Granted Aug 31, 2010 · Expires Aug 26, 2030

    granted
  22. US 7786213

    Biomacromolecule polymer conjugates

    The Regents of the University of California · Granted Aug 31, 2010 · Expires Aug 26, 2030

    granted
  23. US 7786221

    Multi-armed, monofunctional, and hydrolytically stable derivatives of poly (ethylene glycol) and related polymers for modification of surfaces and molecules

    Nektar Therapeutics · Granted Aug 31, 2010 · Expires Aug 26, 2030

    granted
  24. US 7786282

    Nucleic acid molecules encoding TNF-α ligand polypeptides having a CD154 domain

    The Regents of the University of California · Granted Aug 31, 2010 · Expires Aug 26, 2030

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.